Pallavi Mandal and Adam Hill’s proof-of-concept randomised controlled trial to establish if atorvastatin could reduce cough in patients with bronchiectasis is now out in Lancet Respiratory Medicine, demonstrating improved cough on a quality-of-life scale and making interesting observations on the effects upon neutrophil apoptosis.
Mandal, P., Chalmers, J. D., Graham, C., Harley, C., Sidhu, M. K., Doherty, C., Govan, J. W. R., Sethi, T., Davidson, D. J., Rossi, A. G., Hill A.T.
Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.
Lancet Respir Med. (2014) S2213-2600(14);70050-5.